Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2025 07:30 ET | Source: Nutriband Inc.

Nutriband CEO Publishes Letter to Shareholders

2025 Letter to Shareholders
April 11, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

Nutriband increases Patent protection with the addition of Macao
April 04, 2025 17:41 ET | Source: Nutriband Inc.

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

ORLANDO, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it has signed an...
February 21, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Issued new Trademark
February 13, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Partnership Agreement
February 11, 2025 09:00 ET | Source: Nutriband Inc.

Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board

ORLANDO, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced World and European...
February 07, 2025 08:45 ET | Source: Nutriband Inc.

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

U.S. Patent Office issues Notice of Allowance for new patent covering Nutriband's AVERSA™ technology
December 31, 2024 07:00 ET | Source: Nutriband Inc.

Nutriband Issues Letter to Shareholders

CEO Publishes Letter to Shareholders looking over achievements in 2024 and outlook for 2025
December 27, 2024 09:25 ET | Source: Nutriband Inc.

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Chinese Patent for AVERSA extended to Macao